Obstructive sleep apnea syndrome (OSAS) has emerged as a risk factor for cardiovascular disease. A prothrombotic state may affect coagulation and participate in the atherosclerotic process in subjects with OSAS. These alterations in coagulation seem to involve the plasminogen activation system. We evaluated the imbalances of the plasminogen activation system related to OSAS, and we assessed the effects of CPAP on the plasminogen activation system.
The plasminogen system and transforming growth factor-β in subjects with obstructive sleep pnea syndrome: effects of CPAP treatment / Steffanina, Alessia; Proietti, Lidia; Antonaglia, Caterina; Palange, Paolo; Angelici, Elena; Canipari, Rita. - In: RESPIRATORY CARE. - ISSN 0020-1324. - STAMPA. - 63:11(2015), pp. 1643-1651. [10.4187/respcare.03571]
The plasminogen system and transforming growth factor-β in subjects with obstructive sleep pnea syndrome: effects of CPAP treatment
STEFFANINA, ALESSIA;PROIETTI, LIDIA;ANTONAGLIA, CATERINA;PALANGE, Paolo;ANGELICI, Elena;CANIPARI, Rita
2015
Abstract
Obstructive sleep apnea syndrome (OSAS) has emerged as a risk factor for cardiovascular disease. A prothrombotic state may affect coagulation and participate in the atherosclerotic process in subjects with OSAS. These alterations in coagulation seem to involve the plasminogen activation system. We evaluated the imbalances of the plasminogen activation system related to OSAS, and we assessed the effects of CPAP on the plasminogen activation system.| File | Dimensione | Formato | |
|---|---|---|---|
|
Steffanina_Plasminogen_2015.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
696.79 kB
Formato
Adobe PDF
|
696.79 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
